The article reports on a phase IIa trial showing that a single intravenous dose of DMT, combined with structured psychological support, can rapidly reduce depressive symptoms and sustain improvement for up to three months in adults with major depressive disorder.
This finding is of interest to psychology readers because it highlights how brief psychedelic experiences, when paired with targeted therapy, may shift mood symptoms quickly and emphasize the role of therapeutic context in treatment outcomes.
Article Title: Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder
Link to PsyPost Article: https://www.psypost dot org/short-acting-psychedelic-dmt-shows-promise-as-a-rapid-treatment-for-major-depressive-disorder/
Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.
#psychedelics #depression #psychotherapy #DMT #clinicaltrials